AUS
NZ
UK
CA
USA
IND
Health
What Does Summit Therapeutics’ Latest Stock Option Grant Reveal?
December 15, 2024 10:52 PM PST| By Team Kalkine MediaHighlights,Summit Therapeutics Inc. announced inducement awards in compliance with Nasdaq Listing Rule 5635(c)(4).,Six new employees received options for shares as part of their onboarding process.,The awards are part of an equity incentive pool crea...
Innovent Biologics and Eli Lilly Partner to Launch Jaypirca® in Mainland China
December 15, 2024 09:27 PM PST| By Team Kalkine MediaHighlights,Revolutionary BTK Inhibitor:,Jaypirca® is the first FDA-approved non-covalent BTK inhibitor and a novel treatment for relapsed or refractory MCL patients.,Strategic Collaboration in China:,Innovent will lead Jaypirca®’s commercialization i...
Is Organon & Co. (NYSE:OGN) Facing a Decline in Earnings?
December 13, 2024 08:10 AM PST| By Team Kalkine MediaHighlights,Organon & Co. has a low P/E of 3x.,Recent earnings grew by 121%, but three-year growth is negative.,A 33% earnings decline is expected next year.,Organon & Co. a key player in the Healthcare sector, is currently facing challenges reflected...
Brookdale Senior Living (NYSE:BKD) Faces Decline A Look at the Challenges
December 13, 2024 07:19 AM PST| By Team Kalkine MediaHighlights,Brookdale Senior Living stock down 26% over five years.,Revenue has shrunk by 3.3% annually for the past five years.,Recent performance,indicates,potential challenges for future growth.,Brookdale Senior Living Inc.a leading provider of sen...
Agilent Technologies (NYSE:A) Is Now the Right Time to Act?
December 13, 2024 07:18 AM PST| By Team Kalkine MediaHighlights,Agilent Technologies, Inc. saw a notable price increase of over 10% recently.,The stock currently trades about 8.2% below its estimated intrinsic value.,Volatility in Agilent's price movements offers potential opportunities in the future,A...
Is Nyxoah Making Waves in the Healthcare Stock Sector?
December 13, 2024 12:18 AM PST| By Team Kalkine MediaHighlights:,Nyxoah launches Genio system commercially in England,Initial implants carried out at University College London Hospitals,System included in NHS Specialised Services Devices Programme,The healthcare sector continues to evolve with advancem...
Can Acelyrin Navigate Conflicting Market Projections?
December 12, 2024 11:49 PM PST| By Team Kalkine MediaHighlights,Morgan Stanley adjusts Acelyrin's target price downward and assigns an equal weight rating.,Wells Fargo & Company raises Acelyrin's price objective and assigns an overweight rating.,Piper Sandler revises Acelyrin's target price and maintai...
Why Did Sutro Biopharma's Rating Catch Market Attention?
December 12, 2024 11:30 PM PST| By Team Kalkine MediaHighlights:,Sutro Biopharma is a biotechnology company specializing in therapeutic treatments for cancer.,The company's target price was recently revised downward by Wells Fargo & Company.,Despite the price reduction, the stock maintains an "equal we...
Mainz Biomed (NASDAQ: MYNZ) Prices Follow-On Offering to Raise $8.0 Million
December 12, 2024 09:03 PM PST| By Team Kalkine MediaHighlights,Mainz Biomed raises $8.0 million in gross proceeds through a follow-on equity offering.,Series A and B warrants attached to offering could lead to additional dilution for shareholders.,Pricing of $5.85 per unit reflects a premium for new s...
Estimating the Intrinsic Value of Arcus Biosciences, Inc. (NYSE:RCUS)
December 12, 2024 08:40 AM PST| By Team Kalkine MediaHighlights,Arcus Biosciences uses the Discounted Cash Flow.,The company’s estimated equity value stands at US$1.7 billion based on future cash.,The stock appears fairly priced with a 1.6% discount relative to its current trading value.,Arcus Bioscien...
Glaukos Co. (NYSE:GKOS) Reports Revenue Surge
December 12, 2024 08:15 AM PST| By Team Kalkine MediaHighlights,State Street Corp increases stake in Glaukos Co. by 5.3%.,Glaukos reports a 23.9% year-over-year revenue growth.,Stock performance of Glaukos fluctuates between $59.58 and $147.65 in the past year.,Glaukos Co. a leader in ophthalmic medica...
Globus Medical (NYSE:GMED) Soars with Solid Earnings and Growth
December 12, 2024 08:15 AM PST| By Team Kalkine MediaHighlights,State Street Corp increases its stake in Globus Medical by 2.3%.,Globus Medical beats earnings estimates with strong quarterly results.,Institutional interest in Globus Medical continues to grow,State Street Corp recently raised its stake...
Penumbra, Inc. (NYSE:PEN) Outperforms Earnings Expectations
December 12, 2024 08:10 AM PST| By Team Kalkine MediaHighlights,Institutional investors adjust positions.,Earnings exceeded analyst expectations.,Revenue up 11.1% year-over-year.,Penumbra, Inc. is a leading healthcare company specializing in medical devices for neuro and peripheral vascular conditions....
Why Is Arcellx Gaining Traction After UBS Group’s Latest Move?
December 11, 2024 11:32 PM PST| By Team Kalkine MediaHighlights:,Arcellx, Inc.,(NASDAQ:ACLX),experienced a 5.1% increase in its stock price.,UBS Group raised its price target for Arcellx from $106 to $114.,The stock saw lower-than-average trading volume, with only 37,703 shares traded.,Arcellx, Inc. op...
How DaVita (NYSE:DVA) Achieves Impressive Returns on Capital
December 11, 2024 08:40 AM PST| By Team Kalkine MediaHighlights,DaVita’s ROCE grows 20% in five years.,Efficiency boosts DaVita’s returns.,DaVita achieves 115% total return.,DaVita HealthCare Partners Inc. has demonstrated remarkable efficiency within the,NYSE Healthcare Stocks,segment. With a 20% grow...
Evaluating the Price-to-Sales Ratio of Inspire Medical Systems, Inc. (NYSE:INSP)
December 11, 2024 08:40 AM PST| By Team Kalkine MediaHighlights,Inspire Medical Systems has a Price to sales ratio of 7.5x.,Revenue grew 33% last year, 276% over three years.,Analysts predict 19% annual growth over the next three years.,Inspire Medical Systems Inc. has attracted attention with its high...
Institutional Confidence Grows in Revvity, Inc. (NYSE:RVTY)
December 11, 2024 08:30 AM PST| By Team Kalkine MediaHighlights,Fmr LLC increased its stake in Revvity by 40.8% during Q3.,Revvity’s market cap stands at $14.34 billion with steady growth prospects.,The company’s earnings per share surpassed analyst expectations in Q3.,Revvity Inc. is a prominent playe...
Zoetis Inc. (NYSE:ZTS) Reports Strong Earnings and Institutional Support
December 11, 2024 08:10 AM PST| By Team Kalkine MediaHighlights,Zoetis reported a significant revenue increase of 11.6% year-over-year.,The company’s net margin stands at 26.55%, reflecting robust operational efficiency.,Institutional investors continue to hold 92.80% of Zoetis shares.,Zoetis Inc. a le...
Is Rectitude Preparing for a Major Shift as Lock-Up Period Ends?
December 10, 2024 11:05 PM PST| By Team Kalkine MediaHighlights:,Rectitude's lock-up period will expire on December 18th.,2,000,000 shares were issued in the company's initial public offering.,Shares owned by major shareholders and insiders will become eligible for trading.,Rectitude operates in the he...
Why Did Mirum Pharmaceuticals Announce New Inducement Awards This Week?
December 10, 2024 10:56 PM PST| By Team Kalkine MediaHighlights:,Mirum Pharmaceuticals grants inducement awards to five new employees.,The awards consist of non-qualified stock options for 48,400 shares and 24,200 RSUs.,The inducement awards are part of the company's recruitment efforts under its 2020...
